Skip to main content

Beckman Coulter s Revenues Up, Earnings Down in Q1

NEW YORK, May 3 (GenomeWeb News) - Beckman Coulter reported increased revenues but smaller earnings for the first quarter of 2004 today.

 

The company had $536.8 million in revenues, up from $467.3 million during the first quarter last year.

 

R&D expenses increased to $48.1 million, from $45.5 million during the same period in 2003.

 

Net earnings decreased to $35.6 million, or $.57 per share, down from $44.6 million, or $.73 per share, during the first quarter last year.

 

As of March 31, Beckman had $49 million in cash and cash equivalents.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.